Both in Biotechnology
Cel-Sci vs INmune Bio
Over the past year CVM returned −80.1% and INMB returned −26.7%; their daily moves had a correlation of 0.12.
CVM −80.1% INMB −26.7%Growth of $1, one year, split-adjusted
| Metric | CVM | INMB |
|---|---|---|
| Price | $1.41 | $1.32 |
| Market cap | $24.8M | $40.9M |
| Today | +7.63% | −4.35% |
| 1 month | −41.7% | −32.0% |
| 6 months | −19.0% | −14.3% |
| Year to date | −73.2% | −15.4% |
| 1 year | −80.1% | −27.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $255.6K | $18.4M |
| Dividend yield | — | — |
| Volatility (60d) | 95.5% | 65.3% |
| Short % of float | 4.0% | 11.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).